GreenLight Biosciences Holdings, (GRNA) Social Stream



GreenLight Biosciences Holdings, (GRNA): $0.30

0.00 (-0.03%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add GRNA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#195 of 382

in industry

GREENLIGHT BIOSCIENCES HOLDINGS PBC (GRNA) Price Targets From Analysts

Use the tables below to see what analysts covering GREENLIGHT BIOSCIENCES HOLDINGS PBC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-12-08 1 $4 $4 $4 $0.299 1237.79%
2023-05-31 1 $0.3 $0.3 $0.3 $0.299 0.33%

Price Target Last Issued December 8, 2022

GRNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GRNA as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, GREENLIGHT BIOSCIENCES HOLDINGS PBC's number of analysts covering the stock is higher than nearly none of them.
  • In terms of how GREENLIGHT BIOSCIENCES HOLDINGS PBC fares relative to all US stocks, note that its variance in analysts' estimates is lower than nearly 100% of that group.
  • In terms of how GREENLIGHT BIOSCIENCES HOLDINGS PBC fares relative to Healthcare stocks, note that its average analyst price target is higher than 4.67% of that group.
  • In the context of stocks in the small market cap category, GREENLIGHT BIOSCIENCES HOLDINGS PBC's upside potential (average analyst target price relative to current price) is higher than 104.81% of them.

Stocks similar to GREENLIGHT BIOSCIENCES HOLDINGS PBC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FNCH, IKNA, and IPSC.

Make investment decisions regarding GRNA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!